標志性成果 |
1. 1.科研項目 (1)羅氟司特介導NLRP3炎癥小體影響間歇低氧時胰島β細胞功能和細胞焦亡的研究。山西省科技廳自然基金。起止年月:2022年 03 月 至 2025 年 03月,8萬 2. 2.學術論文 [1]Zhihong Liu, Huanhuan Yang, Linping Zhi, Huan Xue, Zhihong Lu, Yanli Zhao, Lijuan Cui, Tao Liu, Shouan Ren, Peifeng He, Yunfeng Liu,Yi Zhang. Sphingosine 1-phosphate stimulates insulin secretion and improves cell survival by blocking voltage-dependent K+ channels in β cells. Frontiers in Pharmacology. 2021, 12; 683674. doi: 10.3389 /fphar.2021.683674. [2] Bo Li, Xiaolu Ren, Hongxia Guo, Yi Guo, Fei Han, Xiaolian Wen, Jing Wu, Xiaomin Li, Yuejun Ren, Xiaoyun Hu, Zhihong Liu. Prognostic role of epidermal growth factor receptor mutation status in patients with de novo lung adenocarcinoma. Translational Cancer Research. 2021;10(3):1549-1558 [3] Xiaolu Ren, Xiaolian Wen, Yue-Jun Ren, Xiang Liu, Jian Wang, Mingyan Hao, Qiang Ma6, Jiwei Ren, Baoli Jin, Xiaoyuan Qiao, Bo Li, Jing Wu, Xiaomin Li, Zhihong Liu. Significance of thyroid transcription factor 1 and Napsin A for prompting the status of EGFR mutations in lung adenocarcinoma patients. Journal of Thoracic Disease; 2022;14(11):4395-4404 3.學術任職 山西省醫(yī)學會呼吸病學分會委員,山西省醫(yī)師協(xié)會呼吸病學分會常務委員 |